We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
Try the New Site
We're building a modernized ClinicalTrials.gov! Visit Beta.ClinicalTrials.gov to try the new functionality.
ClinicalTrials.gov Menu

RCT of the Efficacy of the Ketogenic Diet in the Treatment of Epilepsy

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00564915
Recruitment Status : Completed
First Posted : November 29, 2007
Last Update Posted : November 29, 2007
Information provided by:
Institute of Child Health

Brief Summary:
A study of the efficacy and tolerability of two different ketogenic diets in children with drug resistant epilepsy; children resistant to at least two drugs randomised to reveive diet after baseline or after further 3m control period; in addition randomised to either MCT or classical ketogenic diet.

Condition or disease Intervention/treatment Phase
Epilepsy Dietary Supplement: Ketogenic diet Phase 4

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 145 participants
Allocation: Randomized
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Diagnostic
Official Title: RCT of the Efficacy of the Ketogenic Diet in the Treatment of Epilepsy
Study Start Date : December 2001
Actual Study Completion Date : July 2006

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Epilepsy

Intervention Details:
  • Dietary Supplement: Ketogenic diet
    Ketogenic diet

Primary Outcome Measures :
  1. Change in seizure frequency [ Time Frame: 3 months ]

Secondary Outcome Measures :
  1. Tolerability and assessment of ketosis and growth [ Time Frame: 3 months ]

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Layout table for eligibility information
Ages Eligible for Study:   2 Years to 16 Years   (Child)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • Diagnosis of epilepsy for at least 2 years, resistant to at least two AEDs, at least 7 seizures/week

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00564915

Layout table for location information
United Kingdom
Institute of Child Health, The Wolfson Centre
London, United Kingdom, WC1N 1EH
Sponsors and Collaborators
Institute of Child Health
Layout table for investigator information
Principal Investigator: Helen Cross, Professor UCL Institute of Child Health
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Layout table for additonal information
Responsible Party: Tracy Assari, Institute of Child Health
ClinicalTrials.gov Identifier: NCT00564915    
Other Study ID Numbers: 98NR04
First Posted: November 29, 2007    Key Record Dates
Last Update Posted: November 29, 2007
Last Verified: November 2007
Keywords provided by Institute of Child Health:
Additional relevant MeSH terms:
Layout table for MeSH terms
Brain Diseases
Central Nervous System Diseases
Nervous System Diseases